Home › Research › Topics › enhancing
enhancing
3 studies tagged enhancing, dated 2018-09-13 to 2025-07-01. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Enhancing early detection of cognitive impairment in primary care with the TabCAT-BHA 2025-07-01
- A novel DPP-4 inhibitor Gramcyclin A attenuates cognitive deficits in APP/PS1/tau triple transgenic mice via enhancing brain GLP-1-dependent glucose uptake 2022-01-28
- Metformin attenuates diabetes-induced tau hyperphosphorylation in vitro and in vivo by enhancing autophagic clearance 2018-09-13
Studies
3 studies carry this tag.
Date range
2018 to 2025
Top journals
- Alzheimer's & dementia : the journal of the Alzheimer's Association 1
- Experimental neurology 1
- Phytotherapy research : PTR 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
TabCAT-BHA was well accepted and sustained, offering a scalable solution for cognitive impairment diagnosis in primary care.
-
Enhancing glucagon-like peptide 1 (GLP-1) signaling with a dipeptidyl peptidase IV (DPP-4) inhibitor might exert protective effects on Alzheimer's disease (AD).
-
Diabetes mellitus (DM) can increase the risk of Alzheimer's disease (AD) in patients.